How to Get Azelaic acid Online in France
Learn how to get Azelaic acid online in France through a secure medical consultation. EU doctors review your case within 24 hours for a 40 € one-off fee.

RISPOSTA DIRETTA
Una consultazione online consente a un medico abilitato nell'UE di valutare il tuo caso e, se appropriato, emettere una prescrizione valida in tutta l'UE.
In meno di 4 ore in media
Prescrizione emessa in meno di 4 ore in media se approvata.
Medici abilitati nell'UE
Ogni caso viene valutato da un professionista sanitario abilitato.
Valida in tutta l'UE
Le prescrizioni approvate sono utilizzabili in qualsiasi farmacia dell'UE.
In questo articolo
If you are looking to get Azelaic acid online in France for persistent breakouts, rosacea, or redness, you do not need to wait weeks for an in-person dermatology appointment. Through Hi-Doctor, an EU-licensed doctor reviews your medical questionnaire and uploaded skin photos within 24 hours and issues an official REMPE electronic prescription when clinically appropriate. A 40 € flat consultation covers your complete clinical assessment. The 40 EUR consultation fee is refunded in full if the doctor does not issue a prescription.
Over 50,000 patients have accessed asynchronous medical consultations across Europe, backed by a 4.8/5 Trustpilot rating.
How it works — get your consultation in 4 steps
Securing a prescription for Azelaic acid online in France is straightforward, fully digital, and handled under EU data-protection law (GDPR). There are no waiting rooms, video calls, or appointments to schedule.

- Complete the medical questionnaire: You answer targeted questions regarding your skin type, symptoms, medical history, and current skincare routine.
- Upload skin photos: You provide clear, well-lit photographs of the affected areas so the doctor can accurately grade lesion severity.
- Medical review: An EU-licensed doctor reviews your file within 24 hours and issues a prescription when clinically appropriate.
- Download your prescription: You receive a downloadable REMPE PDF in your secure account inbox. The prescription can be presented at any EU pharmacy, where the pharmacist reviews it and may dispense a locally marketed equivalent.
Who qualifies
Azelaic acid 15% gel (commonly marketed as Skinoren or Finacea) is a versatile first-line topical treatment suitable for mild-to-moderate inflammatory acne, post-inflammatory hyperpigmentation, and papulopustular rosacea. It is often preferred during pregnancy and for darker skin phototypes because it carries a minimal risk of pigmentary changes and does not photosensitise.

Dermatology treatments Hi-Doctor's doctors may prescribe are topical only. Patients presenting with severe, nodular, cystic, or scarring acne, or those requiring oral antibiotics or oral isotretinoin (Roaccutane), fall outside our telemedicine scope and are referred to in-person specialist care.
| Condition / Skin Goal | First-Line Topical Option | Primary Mechanism | Evaluation Window |
|---|---|---|---|
| Mild–Moderate Acne & Hyperpigmentation | Azelaic acid 15% gel (Skinoren / Finacea) | Comedolytic, antibacterial, tyrosinase inhibitor | 12 weeks |
| Comedonal & Inflammatory Acne | Adapalene 0.1% + Benzoyl Peroxide 2.5% (Epiduo) | Retinoid cell turnover + antimicrobial action | 12 weeks |
| Inflammatory Papules & Pustules | Clindamycin 1% + Benzoyl Peroxide gel (Duac) | Antibacterial without resistance risk (max 12 wks) | 8–12 weeks |
What Azelaic-acid actually does
Azelaic acid is a naturally occurring dicarboxylic acid with triple-action clinical utility. First, it exerts an antibacterial effect against Cutibacterium acnes without inducing microbial resistance. Second, its comedolytic property normalises follicular keratinisation, clearing clogged pores. Third, it acts as a mild tyrosinase inhibitor, reducing abnormal melanin production to fade post-inflammatory marks.
Visible changes require physiological skin cycle turnover. Minor purging or initial flaking can occur in weeks 2 to 6. Meaningful improvement is evaluated at 12 weeks of consistent, twice-daily application.
Side effects and when to stop
Azelaic acid is generally well-tolerated compared to harsher retinoids or high-strength peeling agents. However, initial application can cause mild, transient side effects that typically resolve after the first few weeks:
- Mild stinging, tingling, or itching immediately after application
- Localised dryness or mild erythema
- Minor peeling around sensitive areas like the mouth and nostrils
If you experience severe swelling, hives, intense burning, or blistering, discontinue use immediately and seek medical advice. Applying a gentle non-comedogenic moisturiser 15 minutes after the gel can significantly mitigate skin irritation.
Why Hi-Doctor vs. walking into a clinic
Booking a specialist consultation in France often involves lengthy appointment queues and unnecessary travel for routine skincare assessments. Hi-Doctor provides asynchronous online consultations with EU-licensed doctors, issuing cross-border prescriptions containing the elements required by Commission Implementing Directive 2012/52/EU for recognition under Directive 2011/24/EU.

- Fixed pricing: A transparent 40 € one-off consultation for dermatology without recurring charges.
- Fee protection: The 40 EUR consultation fee is refunded in full if the doctor does not issue a prescription.
- Speed and privacy: A doctor reviews your questionnaire and photos within 24 hours and issues a prescription when clinically appropriate.
- Official REMPE standard: Downloadable electronic prescriptions carrying Spain's official private digital format, which can be presented at EU pharmacies where pharmacists may dispense a locally marketed equivalent.
DOMANDE COMUNI
Domande frequenti
High-strength clinical formulations, such as Azelaic acid 15% gel, require a medical evaluation and an official prescription in France. Lower concentrations sold over the counter are often less effective for moderate acne or rosacea. Hi-Doctor connects you with an EU-licensed doctor who can prescribe clinical-strength formulations online when clinically appropriate.





